Ethical Issues in Genetic Screening and Testing, Gene Therapy, and Scientific Conduct

Lisa S. Parker and Elizabeth Gettig
Department of Human Genetics,
University of Pittsburgh,
Pittsburgh, Pennsylvania 15261.


1. Annas GJ. Standard of care. New York: Oxford University Press, 1993;154159, 164166, 181186.

2. Appelbaum PS, Lidz CW, Meisel A. Informed consent: legal theory and clinical practice. New York: Oxford University Press, 1987.

3. Appelbaum PS, Roth LH. Patients who refuse treatment in medical hospitals. JAMA 1983;250:12961301.

4. Barnard D. Unsung questions of medical ethics. Soc Sci Med 1985;21:243249.

5. Beauchamp TL, Childress JF. Principles of biomedical ethics. 3rd ed. New York: Oxford University Press, 1989.

6. Billings P, et al. Discrimination as a consequence of genetic testing. Am J Hum Genet 1992;51(4):899901.

7. Canterbury v. Spence. 464 F.2d 772, 1972.

8. Emmitt RJ. Tardy compassion [Letter]. Lancet 1993;341:1157 1158.

9. Epstein AN. Changes in the delivery of care under comprehensive health care reform. N Engl J Med 1993;329:16721676.

10. Fisher M, ed. U.S. Preventive Services Task Force. Guide to clinical preventive services; an assessment of the effectiveness of 169 interventions. Baltimore: Williams & Wilkins, 1989.

11. Folstein S. Huntington disease. Baltimore: Johns Hopkins University Press, 1989;177187.

12. Forrow L, Arnold RM, Parker LS. Preventive ethics: expanding the horizons of clinical ethics. J Clin Ethics 1993;4:287294.

13. Fost N. Genetic diagnosis and treatment. AJDC 1993;146:11901195.

14. Friedman M. Care and context in moral reasoning. In: Kittay EF, Meyers DT, eds. Women and moral theory. Totowa, NJ: Rowman & Littlefield, 1987.

15. Frye M. The politics of reality: essays in feminist theory. Trumansburg, NY: Crossing Press, 1983.

16. Gelehrter T, Collins F. Principles of medical genetics. Baltimore: Williams & Wilkins, 1990;289297.

17. Harper P. Research samples from families with genetic diseases: a proposed code of conduct. Br Med J 1993;306:13911394.

18. Harper P. Clinical consequences of isolating the gene for Huntington's disease. Br Med J 1993;307:397398.

19. Hasty compassion [Editorial]. Lancet 1993;341:663.

20. Healy B. Remarks for the RAC committee meeting of January 14, 1993, regarding compassionate use exemption. Hum Gene Ther 1993;4:196197.

21. Jennings B. Bioethics and democracy. Centennial Rev 1990; 35(2):207225.

22. Journal of the American Medical Association. Special Issue: Caring for the Uninsured and Underinsured JAMA 1993;265:24372624.

23. Kaback MM, Zeiger RS. The John Kennedy Institute Tay Sachs Program: practical and ethical issues in an adult genetic screening program. In: Condliffe P, Callanhan D, Hilton B, eds. Ethical issues in genetic counseling and the use of genetic knowledge. New York: Plenum Press, 1972.

24. Murray T. Ethical issues in human genome research. FASEB 1991;5:5560.

25. National Society of Genetic Counselors. Code of ethics. Wallingford, PA, 1992.

26. Parker L. Bioethics for human geneticists: models for reasoning and methods for teaching. Am J Hum Genet 1994;54:137147. [Portions of this chapter have appeared previously in this article.]

27. Payer L. Medicine and culture. New York: Henry Holt and Company, 1988.

28. Pincoffs E. Quandary ethics. Mind 1971;80:552571.

29. Position paper on human germ line manipulation presented by Council for Responsible Genetics, Human Genetic Committee, Fall 1992. Hum Gene Ther 1993;4:3537.

30. In the matter of Karen Quinlan. 70 NJ 10, 1976.

31. Ramsey P. The patient as person. New Haven: Yale University Press, 1970.

32. Robinson A, Linden M. Clinical genetic handbook. 2nd ed. Boston: Blackwell Scientific Publications, 1993;465469.

33. Sherwin SS. No longer patient: feminist ethics and health care. Philadelphia: Temple University Press, 1992.

34. Shore D, Berg K, Wynne O, Folstein MF. Legal and ethical issues in psychiatric genetic research. Am J Med Gen 1993;48(1):1721.

35. Starr P. The framework of health care reform. N Engl J Med 1993;329:16661672.

36. Thompson L. Harkin seeks compassionate use of unproven treatments. Science 1992;258:1728.

37. Thompson L. Healy approves an unproven treatment. Science 1993;259:172.

38. Tsuang MT, Faraone SV. Neuropsychiatric genetics: a new specialty section of the American Journal of Medical Genetics [Editorial]. Am J Med Genet 1993;48(1):13.

39. Veatch RM. Models for ethical medicine in a revolutionary age. Hastings Center Rep 1972;2(3):57.

40. Walters L. Human gene therapy: ethics and public policy. Hum Gene Ther 1991;2:115122.

41. Wilfond BS, Fost N. The introduction of cystic fibrosis carrier screening into clinical practice: policy considerations. Milbank Q 1992;70(4):62959.

42. Wilfond BS, Nolan K. National policy development for the clinical application of genetic diagnostic technologies. Lessons from cystic fibrosis. JAMA 1993;270(24):29482954.

43. Wivel N, Walters, L. Germ line gene modification and disease prevention: some medical and ethical perspectives. Science 1993;262:533538.

44. Yesley MS. Bibliography: ethical legal and social implications of the human genome project. U.S. Department of Energy, Washington, DC, 1992.

Back to Chapter

published 2000